With 1300+ tests across oncology, rare diseases, reproductive health and more, we support accurate diagnosis and better patient care. MedGenome is a global genomics and precision diagnostics company focused on enabling accurate, early and actionable diagnosis through advanced genomic science. We operate South Asia’s largest CAP-accredited genetic testing laboratory and offer a comprehensive test menu of more than 1,300 genetic assays across key disease areas. Our diagnostic capabilities span rare inherited disorders, oncology, reproductive health, infectious diseases and preventive wellness. By integrating next-generation sequencing technologies with proprietary assays and AI-enabled bioinformatics platforms, MedGenome delivers high-quality genomic insights that support clinicians in complex clinical decision-making. Founded with a vision to make genomic healthcare affordable and accessible, MedGenome has built deep scientific and clinical expertise backed by extensive research and global collaborations. Our work is supported by a strong research foundation with hundreds of peer-reviewed scientific publications, reflecting our commitment to evidence-based diagnostics and innovation. MedGenome serves clinicians and healthcare institutions across hundreds of locations in India and multiple countries worldwide. Our team of scientists, genome analysts, bioinformaticians and clinical experts works closely with healthcare providers to ensure test accuracy, clinical relevance and timely reporting. We are driven by a commitment to continuous innovation, quality and education. From developing in-house genomics solutions to advancing awareness around genetic testing, MedGenome plays an active role in shaping the future of precision medicine. At MedGenome, every genome decoded strengthens our mission to improve patient outcomes, support clinicians with reliable insights and transform healthcare through the power of genomics.
